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ABSTRACT  
Objectives: To assess the relationship between serum uric acid concentration and 
urinary excretion of uric acid in patients with gout.  
Materials and Methods: Fifty three Sudanese patients with gout were included in this 
study; thirty three of them were gouty subjects not under treatment, twenty subjects 
were under treatment. Twenty normal subjects were used as control. The biochemical 
parameters included in this study were: serum uric acid, urine uric acid. Urine volume, 
pH, specific gravity, and urine crystals were also determined. Results: Serum uric acid 
concentration in gouty subjects not under treatment was significantly higher (p<0.01) 
as compared to control group. While serum uric acid concentration in gouty subjects 
under treatment was not significantly higher than the control group, the difference 
between means was statistically significant between gouty subjects not under treatment 
and control group. No significant differences were found for urine uric acid excretion. 
There was a weak positive correlation between serum uric acid concentration and 
urinary excretion of uric acid in gouty groups; however control group gave a weak 
negative sign. The risk factors, which were considered, were obesity (over weight), 
ethnic origin, and age. The difference between means for body weight and height was 
significantly higher (P<0.05) in gouty subjects compared with control group, and the 
difference between means for urine volume, urine specific gravity, and urine crystalls 
showed no significant effect on the three groups, while urine pH showed significant 
mean difference between these groups.  
Conclusion: The determination of serum uric is of good diagnostic value, whereas 
estimation of urine uric acid is of little diagnostic value.  
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Urine crystals can be used only for screening for the investigation of urine uric acid 
crystals.  
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INTRODUCTION  
Gout is a condition characterized by the deposition of monosodium urate crystals in the 
joints or soft tissues.The four phases of gout include asymptomatic hyperuricemia, 
acute gouty arthritis, intercritical gout and chronic tophaceous gout. The peak incidence 
occurs in patients 30 to 50 years old, and is much more common in men than in women. 
Patients with asymptomatic hyperuricemia do not require treatment, but efforts should 
be made to lower their urate levels by encouraging them to make changes in diet or 
lifestyle. Acute gout most commonly affects the first metatarsal joint of the foot, but 
other joints are also as well involved. Definitive diagnosis requires joint aspiration with 
demonstration of birefringent crystals in the synovial fluid under a polarized light 
microscope (1).  
Gout is associated with hyperuricemia, defined as elevated serum urate concentration 
greater than 7 mg/dl in adult males or 6 mg/dl in adult females (2) .  While hyperuricemia 
may indicate an increased risk of gout, the relationship between hyperuricemia and gout 
is unclear, many patients with hyperuricemia do not develop gout, while some patients 
with repeated gout attacks have normal or low blood uric acid levels.The normal urinary 
excretion of urate is within the range 250-750 mg/24 h. (3) Gibson et al (4) found that 
urate clearance was lower in gouty and hyperuricemic subjects.   
                      
Development of gout from asymptomatic hyperuricemia is often correlated with the 
degree of hyperuricemia as observed in population or family studies, the data presented 
indicate that unequivocal hyperuricemia is more often accompanied by excessive 
excretion of uric acid. (5) Despite wide variation of plasma urate concentration among 
different individuals, daily urate excretion varied little and did not correlate with plasma 
urate (6). The objective of this study is to assess the relationship between the level of 
serum uric acid concentration and urinary excretion of uric acid and related factors in 
gouty patients.  
  
MATERIALS AND METHODS  
This study was carried out in the Gezira State, Central Sudan. 73 subjects were included 
in this study, classified as (known) gouty patients under treatment (n=20), gouty 
patients not under treatment (n=33), and control group (n=20), with an age range of 
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(34-85 yr.) and male to female ratio was 4.3:3. Blood and urine (24 hr.) samples were 
collected from patients at their homes. Blood samples were taken before breakfast, 
venous blood was collected with no anticoagulant, centrifuged and the serum analysed 
immediately after collection.  
24-hour urine volume was collected in a clean plastic container, with no preservative, 
then urine samples were stored in a cold place and analysed within two hours after 
collection. A questionnaire was designed to get information about sex, age, race, history 
of gout, occupation, diet, weight, height, body mass index (BMI), habits, drugs used 
and symptoms. The analysis was done in Gezira Medical Laboratory. Uric acid was 
estimated using an enzymatic colorimetric method (URICASE PAPE, Spin React-
Spain). Urine pH and specific gravity were measured using pH meter (mod.203), 
indicator paper and refractometer respectively. Microscopic examination for detection 
of urate and Ca+-oxalate was done in this study. A sensitive balance was used to 
measure the body weight of the subjects in kilograms.  
Data analysis: All information included in the questionnaire was coded. SPSS and 
Microstat Statistical program was used for the analysis.  
                      
Two parts of analysis were used in this study:  
Part one: Descriptive analysis for the mean, standard deviation, minimum and 
maximum values, were obtained for serum uric acid and urinary excretion of uric acid 
in both control and gouty groups.  
Part two: Analysis of results included, partial correlation, logistic regression, paired 
samples statistics and chi-square test, were the analysis applied to estimate the 
correlation coefficient between serum uric acid and urinary excretion of uric acid, and 
the factors that affect the two variables. P value <0.05 was considered statistically 
significant.   
  
RESULTS  
The results of serum uric acid concentration and 24-hr urinary excretion of uric acid are 
presented in (Table U). Serum uric acid in gouty subjects not under treatment (7.8 
mg/dl) was significantly higher than that of control (6.15 mg/dl) subjects (P<0.001), 
however serum uric acid in gouty subjects under treatment (6.9 mg/dl) was not 
significantly higher than that of the control (6.15 mg/dl) group. The difference between 
means for serum uric acid in gouty subjects undergoing treatment and gouty subjects 
not under treatment was statistically not significant. The difference between means for 
urine uric acid in control group (462.3 mg/24hr), gouty subjects under treatment (450.7 
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mg/24 hr), and gouty subjects not under treatment (479.2 mg/24 hr), was statistically 
not significant. Table (U) shows that the correlation coefficient between serum uric acid 
concentration and urinary excretion of uric acid for control and gouty subjects is weak, 
but it has a positive sign for gouty subjects. In Table (2) the mean age was found to be 
higher in gouty subjects under treatment than that of gouty subjects not under treatment 
and control group. The mean for body weight and height was significantly higher 
(P<0.05) in gouty subjects compared with control group.Body mass index (BMI) was 
found higher in gouty groups compared to control group, and the difference between 
means was significant (P<0.05) between gouty  subjects under treatment and control 
group. The mean urine pH showed significant difference (P<0.05) between gouty 
groups, while urine volume and specific gravity showed no significance among the 
three groups. Urine differences in crystals and other related diseases are shown in Table 
(3).  
  
Table (E) Mean, standard deviation, minimum, maximum, and correlation coefficient 
values for serum uric acid and urinary excretion of uric acid.  
  
  N  Serum uric acid mg/dl  Urine uric acid (mg/dl)  Co  Si  
Control  
Min  
  
Level  
Max  
Level  
Mean  
–STD  
Min  
Level  
Max   
Level  
Mean–STD  
Gouty 
subjects 
under 
treatment  
20  4.5  9.0  6.15–1.39  180  799  462.3–196.2  0.09  NS  
Gouty 
subjects  
notunder 
treatment  
20  3.0  10.0  6.96–2.20  124  814  450.7–169.2  0.06  NS  
  33  4.5  12.0  7.8–1.83  160.0  972  469.2–180.8  0.02  NS  
  
N= Number of samples  
S= Significant (P<0.05)   
NS= Not Significant  
STD= Standard deviation  
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Table (2 ; A&B) : The difference of the means and standard deviation of the age, body 
weight, body height, body mass index, urine pH, urine volume, and urine specific 
gravity.  
  
Table 2; A  
Sample group  N   (%)  Age   
Mean–STD  
Body weight 
Mean–STD  
Body height 
Mean–STD  
Control  
Gouty under treatment  
20     (27)   
20    (27)  
55.6–10.6   
61.3–15.2  
71.0–13.9   
85.5–14.0  
170.1–5.69   
175.2–7.45  
Significance    NS  S  S  
Control  
Gouty under treatment  
20     (27)   
33     (46)  
55.6–10.6   
58.9–10.3  
71.0–13.9   
79.6–11.8  
170.1–5.69   
175.6–5.45  
Significance    NS  S  S  
Gouty under treat  
Gouty not under treat.  
20      (27)   
33     (46)  
61.3–15.2   
58.9–10.3  
85.5–14.0   
79.6–11.8  
175.2–7.45   
175.6–5.45  
    NS  NS  NS  
  
Table 2; B  
Sample group  Body 
 mas
s  
index  
Mean–STD  
Urine PH  
  
Mean–STD  
Urine volume 
Mean–STD  
Urine SG  
  
Mean–STD  
Control  
Gouty under treatment  
24.4–4.5   
27.2–4.0  
55.6–10.6   
61.3–15.2  
5.1–0.54   
5.2–0.45  
968.0–430.7   
1259.5–650.4  
Significance  S  NS  NS  NS  
Control  
Gouty under treatment  
24.4–4.5   
25.7–2.6  
55.6–10.6   
58.9–10.3  
5.1–0.54   
4.9–0.57  
968.0–430.7   
1324.3–772.7  
Significance  NS  NS  NS  NS  
Gouty under treatment 
Gouty not under treat.  
27.2–4.0   
25.7–2.6  
61.3–15.2   
58.9–10.3  
5.2–0.45   
4.9–0.57  
1259.5–650.4   
1324.3–772.7  
  NS  NS  S  NS  
  
N= number of samples  
S= significant (P<0.05)  
NS= Not significant  
STD= Standard deviation  
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Table (3) Frequency and percentage of other related diseases and urine crystals.  
Type of disease  Total 
No.  
Gouty patients 
under treatment  
Gouty patients 
not under 
treatment  
Control  
Freq.  %  frequ  percent  freq  %  
Rheumatoi  16  7  35  8  24.2  1  5  
Hypertension  15  5  25  9  27.3  1  5  
Diabetes mellitus  1  0  0  1  3  0  0  
DM&HTN  2  0  0  2  6.1  0  0  
Uric acid crystals  10  3  15  5  15.2  2  10  
Calcium oxalate  
crystals  
5  2  10  1  3  2  10  
Calcium oxalate&  
Uric acid Crystals  
13  2  10  4  12.1  7  35  
  
  
DISCUSSION  
Biochemical investigation of gout usually depends on serum uric acid determination. In 
this study we analysed uric acid excretion in addition to serum uric acid, because 
accurate determination of serum uric acid and urinary excretion of uric acid is essential 
for the diagnosis and classification of gout according to uric acid metabolism (7) , while 
Cantarow and Trumper (8) reported that determination of uric acid excretion in gout was 
of little practical importance.  
In this study there was a negative correlation between serum uric acid concentration 
and urinary excretion of uric acid in control group, this result agrees with the result 
reported by lang et al (6) , who found that there was clear cut negative correlation 
between plasma urate concentration and fractional urate clearance in normal subjects, 
also this result seems to agree with Puig et al and Sota et al (9,10) , who found a significant 
inverse correlation between uric acid clearance and serum uric acid concentration in 
normal control. But we found a weak positive correlation in the two groups of gouty 
subjects, this result is in agreement with the result reported by Yau and Kaung (5)  , who 
showed that unequivocal hyperuricemia, is more often accompanied by excessive 
excretion of uric acid. In more than 75% of patients with gout there appear to be a 
genetically determined defect in fractional urate excretion which results in an inability 
to increase excretion in response to a purine load (11). Those under treatment are affected 
with the drugs used, which reduces circulating urate and also reduces urate excretion 
(3). From the quessionnaire, age was found to be higher in gouty subjects copared with 
control group, while it shows a negative association with serum uric acid. Body weight 
was significantly higher in gouty subjects compared to control group, also it was 
positively correlated with serum uric acid and urinary excretion of uric acid, this result 
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agrees with the result reported by Loenen et al (12), Nishioka and Mikanagi (13), who 
found a positive correlation between serum uric acid and body weight, but Reuter et al 
(14), showed no correlation between them. So reducing body weight is one of the 
effective measures to prevent and treat gout or hyperuricemia in elderly (15). Height was 
significantly greater in gouty subjects compared with control group; this finding 
indicates that height was strongly associated with serum uric acid concentration. Body 
mass index (BMI) was higher in gouty subjects compared to control group, this result 
was in line with Saggiani et al (16), who reported that BMI was one of the major 
predictors of the urate levels.This finding is also similar to that obtained by Al arfaj (17) 
who found that uric acid levels correlated significantly with BMI in males and females. 
Mean serum uric acid levels were correspondigly higher in hypertensive than non 
hypertensive peoples, while some of the univariate relation of serum uric acid to blood 
pressure is apparently due to the strong relation of body mass to both serum uric acid 
and blood pressure, they concluded that hypertension is one of the significant risk 
factors in both men and women with gout (18, 19, 20, 21). These results reflect the high 
number of gouty patients with increased BMI and hypertension as shown in Tables (1) 
and (2). Consequently, measures to effect predisposing and associated conditions 
should be taken including, weight reduction, physical exercise and diet guidance, 
treatment of hypertension and possibly changes in medication (22). Patients with gout or 
hyperuricemia have some times acidic urine, and increased urine uric acid excretion 
(21). In this study urine PH was lower in gouty subjects not under treatment than that of 
control and gouty subjects under treatment; this finding indicates that low purine high 
vegetable diets were required to increase urine pH, inspite of the confounding variation 
of the purine rich diet in the three groups. Table (3) showed high number of patients 
with rheumatoid due to high erythrocyte sedimentation rate (ESR) level which was 
found significantly higher and correlated with serum uric acid in females (17).  
28 gouty patients out of 53 were suffering from renal crystals with low urine PH. Since 
most of the urinary calculi were composed of uric acid, stone formation can be reduced 
by alkalization of the urine (23).  
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